I know you like interesting papers that can give +20-30% This | 🚀 Robin Rocket

I know you like interesting papers that can give +20-30%

This is especially true if we are talking about biopharm in the medium and long term. Catch one of the ideas:

Arena Pharmaceuticals, $ARNA

Current price: $61.22
Target price: $75-79

Arena Pharmaceuticals, Inc. is an American biopharmaceutical company from California that develops low molecular weight drugs for clinical use in various therapeutic areas. The company was founded in 1997.

Arena technology is the result of two decades of GCPR research.

The company went public in 2000, raising about $73 million to develop a drug development platform called CART (Constitutively Activated Receptor Technology), which resulted in the approval and launch of Belviq, the first weight loss drug approved in the United States in 13 years.

The Arena analyst consensus is between $92 and $105.

Not an investment recommendation.